Recent advances in the longitudinal segmentation of multiple sclerosis lesions on magnetic resonance imaging: a

Marcos Diaz-Hurtado1, Eloy Martínez-Heras2, Elisabeth Solana2

  • 1E-Health Center, Universitat Oberta de Catalunya, Barcelona, Spain. mdiazhu@uoc.edu.

Neuroradiology
|July 21, 2022
PubMed

Insights

Automated segmentation of multiple sclerosis (MS) lesions using longitudinal MRI data improves tracking of disease progression. Deep learning techniques show promise for more accurate lesion detection and monitoring treatment response over time.

Area of Science:

  • Neurology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune disease impacting the central nervous system.
  • Magnetic resonance imaging (MRI) is crucial for visualizing demyelinating lesions in MS.
  • Accurate lesion segmentation is vital for monitoring disease burden and treatment efficacy.

Purpose of the Study:

  • To review longitudinal MS lesion segmentation methods published in the last decade.
  • To compare traditional machine learning with deep learning techniques for MS lesion segmentation.
  • To highlight the advancements in automated lesion detection using multi-time-point MRI data.

Main Methods:

  • Systematic review of PubMed articles focusing on longitudinal MS lesion segmentation.
  • Selection criteria included studies using longitudinal information and comparing automated two-time-point segmentations.
  • Analysis of 19 selected articles categorized into traditional machine learning and deep learning approaches.

Main Results:

  • Automated methods offer objectivity and speed compared to manual lesion delineation.
  • Longitudinal segmentation methods enhance the detection of new lesions and changes in existing ones.
  • Deep learning techniques are increasingly prevalent and show significant promise in this field.

Conclusions:

  • Longitudinal lesion segmentation using automated methods, particularly deep learning, is crucial for understanding MS progression.
  • These advanced techniques can provide more sensitive biomarkers for disease monitoring and treatment response evaluation.
  • Further research into deep learning for longitudinal MS lesion segmentation is warranted to improve patient care.